Publications by authors named "Koen de Heer"

Claim this Profile
R
Real-world efficacy and safety of immunochemotherapy in cold agglutinin-mediated autoimmune haemolytic anaemia.
Femke V M Mulder, Anne-Marie L Becking, Sophie J Bernelot Moens, Marit Jalink, Dorothea Evers, Koen de Heer

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-duration ibrutinib-venetoclax with MRD-guided ibrutinib-obinutuzumab intensification in first-line chronic lymphocytic leukaemia (HOVON 158/NEXT STEP): primary analysis of a multicentre, open-label, phase 2 trial.
Arnon P Kater, Sabina Kersting, Julie M Dubois, Bronno van der Holt, Caspar da Cunha-Bang, Koen de Heer

Lancet Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncovering the ultra-frail: A distinct subgroup in non-transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome.
Kazimierz Groen, Febe Smits, Kazem Nasserinejad, Mark-David Levin, Josien C Regelink, Koen de Heer

Hemasphere· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frail subgroups determine heterogeneous outcomes in older patients with NDMM: long-term follow-up of the HOVON 143 trial.
Febe Smits, Kaz Groen, Mark-David Levin, Claudia A M Stege, Roel van Kampen, Koen de Heer

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose iron chelation as anti-oxidative therapy in patients with sickle cell disease: A single-centre pilot study.
Aafke E Gaartman, Boukje M Beuger, Lydian A de Ligt, Martijn Veldthuis, Hanke L Matlung, Koen de Heer

Br J Haematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma.
Febe Smits, Kaz Groen, Mark-David Levin, Claudia A M Stege, Roel van Kampen, Koen de Heer

Blood· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes.
Kazimierz Groen, Febe Smits, Kazem Nasserinejad, Mark-David Levin, Josien C Regelink, Koen de Heer

Hemasphere· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS.
A Vera de Jonge, Carolien Duetz, Wassilis S C Bruins, Charlotte L B M Korst, Rosa Rentenaar, Koen de Heer

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.
Kaz Groen, Claudia A M Stege, Kazem Nasserinejad, Koen de Heer, Roel J W van Kampen

EClinicalMedicine· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia.
Sabine Haggenburg, Hannah M Garcia Garrido, Iris M J Kant, Hanneke M Van der Straaten, Fransien De Boer, Koen De Heer

Vaccines (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic value of Chest X-Ray in Febrile Patients without Localizing Signs or Symptoms at the Emergency Department.
Charlotte A L Jonker, Liza Pereverzeva, Sacha F de Stoppelaar, Koen de Heer

Curr Med Imaging· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group.
Doreen G Te Raa, Lina van der Straten, Michel van Gelder, Sabina Kersting, Mark-David Levin, Koen de Heer

Leuk Lymphoma· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Visual/Verbal Analogue Scale of Food Ingesta (Ingesta-VVAS) in Oncology Patients Undergoing Chemotherapy.
Hanneke A H Wijnhoven, Loïs van der Velden, Carolina Broek, Marleen Broekhuizen, Patricia Bruynzeel, Koen de Heer

Nutrients· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy.
Karima Amaador, Luuk Wieske, Marleen J A Koel-Simmelink, A Kamp, Ilse Jongerius, Koen de Heer

J Neurol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas.
Anne W J Martens, Joanne M Rietveld, Renate de Boer, Fleur S Peters, An Ngo, Koen de Heer

Cancer Res Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors.
Aafke E Gaartman, Ajab K Sayedi, Jorn J Gerritsma, Tim R de Back, Charlotte F van Tuijn, Koen de Heer

Br J Haematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia.
Raquel Delgado, Karoline Kielbassa, Johanna Ter Burg, Christian Klein, Christine Trumpfheller, Koen de Heer

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
Paul G Kemps, Konnie M Hebeda, Steven T Pals, Robert M Verdijk, King H Lam, Koen de Heer

J Pathol Clin Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine.
Maria T Kuipers, Rob van Zwieten, Jarom Heijmans, Caroline E Rutten, Koen de Heer

Am J Hematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Value of Chest X-Ray in Patients With Suspected Infection and No Respiratory Signs or Symptoms.
Sacha F de Stoppelaar, Liza Pereverzeva, Bram Hafkamp, Nikki Lips, Floor Tielbeke, Koen de Heer

Open Forum Infect Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial.
Anja van der Hout, Cornelia F van Uden-Kraan, Karen Holtmaat, Femke Jansen, Birgit I Lissenberg-Witte, Koen de Heer

Lancet Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chest X-ray in patients with fever and no localizing symptoms?].
E Pereverzeva, Sacha F de Stoppelaar, Koen de Heer

Ned Tijdschr Geneeskd· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.
Koen de Heer, Marije G Gerritsen, Caroline E Visser, Mariska Mg Leeflang

Cochrane Database Syst Rev· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia.
Alexander C Leeksma, Justin Taylor, Bian Wu, Jeffrey R Gardner, Jie He, Koen de Heer

Leukemia· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early discharge after high dose chemotherapy is safe and feasible: a prospective evaluation of 6 years of home care.
Arno P M Mank, Charlot Schoonenberg, Kim Bleeker, Susanne Heijmenberg, Koen de Heer

Leuk Lymphoma· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis